Skip to main content
. 2017 Jan 18;32(1):264–270. doi: 10.1080/14756366.2016.1247061

Table 2.

1H NMR data and main fragments in E.I. mass spectrometry of derivatives EMAC II (im).

Compound 1H NMR δ (ppm)
EMAC II i 1H-NMR: (300 MHz, CDCl3) δH 2.38 (s, 3H, CH3), 3.23 (dd, 1H, Jab 16.5, Jax 7.8, CH2, isoxazole), 3.76 (dd, 1H, Jab 16.5, Jbx 10.1, CH2, isoxazole), 5.59 (dd, 1H, Jbx 10.8, Jax 8.1, CH, isoxazole), 7.21 (d, 2H, J 7.8, CH, arom.), 7.33 (m, 4H, CH, arom.), 7.57 (2H, d, J 8.1, CH, arom.).
EMAC II j 1H-NMR: (300 MHz, CDCl3) δH 2.37 (s, 3H, CH3), 2.43 (s, 3H, CH3), 3.30 (dd, 1H, Jab 16.5, Jax 8.3, CH2, isoxazole), 3.72 (dd, 1H, Jab 16.5, Jbx 10.8, CH2, isoxazole), 5.66 (dd, 1H, Jbx 10.8, Jax 8.3, CH, isoxazole), 7.16–7.29 (m, 6H, CH, arom.), 7.57 (d, 2H, J 8.3, CH, arom.).
EMAC II k 1H-NMR: (300 MHz, CDCl3) δH 2.35 (s, 3H, CH3), 3.27 (dd, 1H, Jab 16.7, Jax 8.0, CH2, isoxazole), 3.74 (dd, 1H, Jab 16.5, Jbx 10.7, CH2, isoxazole), 5.69 (dd, 1H, Jbx 10.7, Jax 8.3, CH, isoxazole), 7.04 (t, 2H, J 8.3, CH, arom.), 7.21 (d, 2H, J 8.1, CH, 4-CH3-phenyl), 7.36 (dd, 2H, CH, J 8.3/5.3, arom.), 7.56 (d, 2H, J 8.2, CH, 4-CH3-phenyl).
EMAC II l 1H-NMR: (300 MHz, CDCl3) δH 2.38 (s, 3H, CH3), 3.27 (dd, 1H, Jab 16.7, Jax 7.8, CH2, isoxazole), 3.78 (dd, 1H, Jab 16.4, Jbx 10.8, CH2, isoxazole), 5.67 (dd, 1H, Jbx 10.8, Jax 7.8, CH, isoxazole), 7.21 (m, 3H, CH, arom.), 7.44 (d, 1H, J 8.2, CH, arom.), m, 7.49 (d, 1H, J 1.2, CH, arom.), 7.56 (d, 2H, J 8.1, CH, arom.).
EMAC II m 1H-NMR: (300 MHz, CDCl3) δH 2.38 (s, 3H, CH3), 3.30 (dd, 1H, Jab 16.7, Jax 7.8, CH2, isoxazole), 3.71 (dd, 1H, Jab 16.5, Jbx 10.6, CH2, isoxazole), 3.80 (s, 3H, OCH3), 5.66 (dd, 1H, Jbx 10.5, Jax 8.6, CH, isoxazole), 6.89 (d, 2H, J 8.3, CH, arom.), 7.21 (d, 2H, J 8.2, CH, 4-CH3-phenyl), 7.31 (d, 2H, J 8.7, CH, arom.), 7.58 (d, 2H, J 8.2, CH, 4-CH3-phenyl).